A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologiesin vitro
出版年份 2015 全文链接
标题
A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologiesin vitro
作者
关键词
-
出版物
JOURNAL OF NEUROCHEMISTRY
Volume 133, Issue 3, Pages 440-451
出版商
Wiley
发表日期
2014-12-30
DOI
10.1111/jnc.13018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
- (2014) Walter Becker et al. CNS & Neurological Disorders-Drug Targets
- Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology
- (2014) Claire H. Michel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Tau protein kinases: Involvement in Alzheimer's disease
- (2012) Ludovic Martin et al. AGEING RESEARCH REVIEWS
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
- (2012) J. Brouillette et al. JOURNAL OF NEUROSCIENCE
- Leucettines, a family of pharmacological inhibitors of DYRKs & CLKs kinases derived from the marine sponge Leucettamine B
- (2012) T Tahtouh et al. PLANTA MEDICA
- Trans-Synaptic Spread of Tau Pathology In Vivo
- (2012) Li Liu et al. PLoS One
- Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing
- (2011) Mansour Debdab et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
- (2011) W. Qian et al. NUCLEIC ACIDS RESEARCH
- β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
- (2011) Danielle Frost et al. PLoS One
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- The role of DYRK1A in neurodegenerative diseases
- (2010) Jerzy Wegiel et al. FEBS Journal
- Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression
- (2010) Yun Li et al. NEUROPHARMACOLOGY
- DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort
- (2009) José Luis Vázquez-Higuera et al. BMC Medical Genetics
- Function and regulation of Dyrk1A: towards understanding Down syndrome
- (2009) Joongkyu Park et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
- (2009) Nora Göckler et al. FEBS Journal
- Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
- (2009) Fayçal Guedj et al. PLoS One
- The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome
- (2008) Jerzy Wegiel et al. ACTA NEUROPATHOLOGICA
- Tau as a biomarker of neurodegenerative diseases
- (2008) Susanna Schraen-Maschke et al. Biomarkers in Medicine
- Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
- (2008) Nicolas Sergeant et al. Expert Review of Proteomics
- Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome
- (2008) Jianhua Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- The amino terminus of tau inhibits kinesin-dependent axonal transport: Implications for filament toxicity
- (2008) Nichole E. LaPointe et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease
- (2007) Soo-Ryoon Ryoo et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started